课题基金 / 基金详情

Private infusion care for high-cost biologic medicines: Investigating the implications for the public healthcare system

Private infusion care for high-cost biologic medicines: Investigating the implications for the public healthcare system
高成本生物药品的私人输液护理：调查对公共医疗保健系统的影响
批准号：
467969
负责人：
Grundy Quinn
金额：
$22.29万
依托单位：
University of Toronto
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-09-01 至 2025-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=467969&lang=en
关键词：
Biologics/Biosimilars High-Cost Medicines Pharmaceutical Industry Pharmaceutical Policy Privatization Qualitative Methods

项目摘要

项目成果

Grundy Quinn的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Biologic medicines, among the most expensive medications ever sold in Canada, require administration by intravenous (IV) infusion every 6-8 weeks. To encourage their use, pharmaceutical companies set up a network of private infusion outpatient clinics whe
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Addressing risks of bias in commercially available mobile health apps
Exploring the interactions between Registered Nurses and industry in clinical practice.